APR 21, 2017 11:08 AM PDT

Classic Heart Attack Drug Finds Resurgence

WRITTEN BY: Kara Marker

Metoprolol is a classic drug for everything heart-related: preventing chest pain, lowering high blood pressure, and reducing damage that can occur during a heart attack. The vessel-relaxing drug has been on the market for more than three decades, but a new study’s results show that metoprolol is not a beta-blocker to be forgotten.

Magnetic resonance imaging (MRI) of the heart of a patient after a heart attack. The major heart muscle surrounds the left ventricle, and healthy muscle appears black on MRI. After an infarction, the necrotic portion of the heart appears white on MRI after injection of a contrast agent. Credit: CNIC

As a beta-blocker, metoprolol relaxes blood vessels to reduce heart rate, lowering blood pressure and improving blood flow. These activities are extremely beneficial for someone in the midst of a heart attack, technically known as acute myocardial infarction.

Treatment for heart attack survivors has improved in the past decade, but the value of intervening when the heart attack is actually happening remains significant and life-saving. "The most important thing is to re-establish blood flow as soon as possible,” explained cardiologist and research team leader Dr. Borja Ibáñez on what to do immediately after a person shows signs of heart attack. “But unfortunately the incoming blood sets off an inflammatory process, started by neutrophils, that causes additional, permanent damage to the heart."

Neutrophils are immune cells that you want on your side when you are fighting a microbial infection, but these cells should be on the sidelines in most other situations. However, immune cells are prone to activating inflammation even when it is unnecessary, which can lead to excessive damage in a situation like a heart attack that makes recovery even more difficult.

Researchers from the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Spain revisited metoprolol and its effect on the heart when administered early during heart attack. While it was known that metoprolol had a pressure-lowering effect that benefitted heart attack sufferers, it was not clear what the drug was doing to the body to achieve it.

Their studies showed that metoprolol inhibits the inflammatory action of neutrophils, reducing overall inflammation that could otherwise have caused widespread tissue damage in the heart muscle.

"Metoprolol stuns the blood neutrophils, altering their behavior and limiting their injurious inflammatory action on cardiac muscle," explained first author Jaime García-Prieto. Without this intervention, neutrophils kill the weak but alive cells, adding to an already dangerous level of tissue damage.

With a fresh understanding of how veteran drug for heart disease, metoprolol, can protect the heart from excessive tissue damage, scientists now have a better way to prevent destruction from happening in the first place during a heart attack, making the best out of a dangerous medical situation.

The present study was published in the journal Nature Communications.

Sources: MedlinePlus.govCentro Nacional de Investigaciones Cardiovasculares Carlos III

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 16, 2020
Health & Medicine
JAN 16, 2020
Babies in Africa Receive World's First Malaria Vaccine
Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the...
JAN 21, 2020
JAN 21, 2020
New Coronavirus is Spreading in China
In late December, health officials in China notified WHO that pneumonia with an unknown cause was sickening people....
JAN 24, 2020
JAN 24, 2020
Immune "Recycling" Could Improve Cancer Immunotherapy
A natural housekeeping function performed by many cells of the human body, including those in the immune system, is under intense scrutiny for its potentia...
JAN 24, 2020
Cannabis Sciences
JAN 24, 2020
Sting Operation: Underage Customers Can't Buy Cannabis
Cannabis retailers in Colorado, Washington and Oregon have received top marks in secret tests to determine whether they were selling to underage buyers (yo...
FEB 11, 2020
Clinical & Molecular DX
FEB 11, 2020
Portable device turns smartphones into diagnostic labs
Your smartphone lets you connect with friends, stores your memories, sends work emails and pays for your groceries. Soon, it could even help diagnose if yo...
FEB 10, 2020
Cell & Molecular Biology
FEB 10, 2020
Lighting a Path to an Alzheimer's Disease Treatment
Alzheimer's impacts millions of people around the world; globally, it is thought to cost $605 billion a year, and there is still no way to treat it....
Loading Comments...